Here are the 8-K filings from Piermont Valley Acq (CMCAF) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow CMCAF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CMCAF filings page.
Piermont Valley Acquisition Corp (symbol: CMCAF) is the issuer of record for a Form 8-K filing submitted to the SEC.
Tigerless Health, Inc., a New York-based Insurtech platform, has agreed to a definitive business combination with Piermont Valley Acquisition Corp., a publicly traded SPAC, valuing Tigerless Health at an enterprise value of approximately $280 million.
After closing, the combined company is expected to be renamed Tigerless AI Holdings, Inc. and listed on NASDAQ, with all existing Tigerless Health shareholders rolling 100% of their equity. The deal is intended to support continued investment in the company’s proprietary AI capabilities that help consumers understand and navigate insurance.
The boards of both companies have unanimously approved the transaction, which is expected to close in the second half of 2026, subject to shareholder and regulatory approvals and other customary closing conditions. Founder and CEO Zikang Wu and his management team are expected to continue leading the combined company.
Piermont Valley Acquisition Corp. reported a Board change. On February 24, 2026, director Brian Coad resigned from the company’s Board of Directors.
The company stated that Mr. Coad’s resignation was not due to any disagreement regarding its operations, policies, or practices.
Piermont Valley Acquisition Corp. held an extraordinary general meeting of shareholders on March 2, 2026, where an extension proposal was approved. A quorum of 5,950,000 Class A ordinary shares and one Class B ordinary share was represented. The proposal received 5,950,000 votes in favor, none against and one abstention. Because this proposal passed and quorum was present, a planned adjournment proposal was not put to a vote. In connection with the extension, 536 Class A ordinary shares were redeemed. After these redemptions, 5,954,419 Class A ordinary shares and one Class B ordinary share were outstanding. An amendment to the company’s Amended and Restated Memorandum and Articles of Association to implement the extension has been filed with the Cayman Islands Registrar of Companies.